192 results
8-K
EX-99.1
FOLD
Amicus Therapeutics Inc
28 Feb 24
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
7:02am
the goals, progress, timing, and outcomes of discussions with regulatory authorities and pricing and reimbursement authorities, are based on current … approval; the potential that we may not be successful in negotiations with pricing and reimbursement authorities; the potential that we may
8-K
EX-99.2
FOLD
Amicus Therapeutics Inc
28 Feb 24
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
7:02am
the goals, progress, timing, and outcomes of discussions with regulatory authorities and pricing and reimbursement authorities, are based on current … product approval; the potential that we may not be successful in negotiations with pricing and reimbursement authorities; the potential that we may
8-K
EX-99.1
mevhgu vfwq3lxn
8 Jan 24
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
7:01am
8-K
EX-99.2
60tsv ctbz8x60yky
8 Jan 24
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
7:01am
S-3ASR
coh49kz3hqw1iclb6j
8 Nov 23
Automatic shelf registration
5:25pm
8-K
EX-99.2
6shetdg5zjitf9apw4u
8 Nov 23
Amicus Therapeutics Announces Third Quarter 2023 Financial Results and Corporate Updates
7:00am
8-K
EX-10.2
0lm92sc
2 Oct 23
Entry into a Material Definitive Agreement
8:48am
8-K
EX-10.1
ysel4ekd4ew4dh 2uaov
2 Oct 23
Entry into a Material Definitive Agreement
8:48am
8-K
EX-99.1
pr7 0iah29
27 Sep 23
AT THE FOREFRONT OF THERAPIES FOR RARE DISEASES Corporate Overview September 2023
7:00am
8-K
EX-99.1
l9eu7v7yz yxt
15 Aug 23
Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the United Kingdom
7:00am
8-K
68yynlg
15 Aug 23
Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the United Kingdom
7:00am
8-K
EX-99.2
zdctb536g
8 Aug 23
Amicus Therapeutics Announces Second Quarter 2023 Financial Results and Corporate Updates
7:00am
8-K
EX-99.1
j1bqjw99pqe79cn 4iha
8 Aug 23
Amicus Therapeutics Announces Second Quarter 2023 Financial Results and Corporate Updates
7:00am